Charles River reaffirms 2026 guidance and sets 2027-2030 targets
Charles River Laboratories reaffirmed 2026 guidance and outlined 2027—2030 targets including 5%—7% organic revenue CAGR and about 24% non-GAAP operating margin by 2030. It also launched the Create the Future program and aims for $300M+ savings.